DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xeloda (Capecitabine) - Current Clinical Trials

 
 



Xeloda Related Clinical Trials

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma [Terminated]

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer [Active, not recruiting]

Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers [Completed]

Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer [Completed]

A Study of Capecitabine [Xeloda] and Concomitant Radiation Therapy in Children and Adolescent Patients With Newly Diagnosed Brainstem Glioma [Recruiting]

Capecitabine (XELODA) With Or Without Lapatinib(GW572016)For Women With Refractory Advanced or Metastatic Breast Cancer [Active, not recruiting]

Study of Capecitabine to Treat Recurrent High Grade Gliomas [Recruiting]

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda�) in Subjects With Advanced Solid Tumors [Recruiting]

A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer [Active, not recruiting]

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma [Terminated]

A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. [Active, not recruiting]

A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer [Recruiting]

A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together [Active, not recruiting]

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy [Completed]

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma [Recruiting]

Study of IMC-18F1 or Ramucirumab DP in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients [Recruiting]

XERAD: A Study of Xeloda (Capecitabine) Plus Radiotherapy in Patients With Breast Cancer With Newly Diagnosed Brain Metastases [Recruiting]

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC [Completed]

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer. [Recruiting]

XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib [Recruiting]

Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer [Recruiting]

Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer [Recruiting]

A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer [Recruiting]

Xeloda (Capecitabine) and External Beam Radiation [Recruiting]

Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma [Active, not recruiting]

Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer [Recruiting]

Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction [Recruiting]

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC) [Recruiting]

Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer [Recruiting]

A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours [Recruiting]

Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer [Active, not recruiting]

Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer [Recruiting]

Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism [Not yet recruiting]

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer [Not yet recruiting]

LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients [Recruiting]

Standard Versus Continuous Capecitabine in Advanced Breast Cancer [Recruiting]

A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression [Recruiting]

Study of BKM120 or BEZ235 and Capecitabine in Patients With Metastatic Breast Cancer [Recruiting]

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer [Completed]

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma [Recruiting]

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Recruiting]

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. [Recruiting]

Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer [Not yet recruiting]

Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma [Recruiting]

Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer [Recruiting]

A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer [Recruiting]

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer [Not yet recruiting]

Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma [Recruiting]

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Recruiting]

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis [Recruiting]

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Recruiting]

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy [Recruiting]

Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab [Recruiting]

Second Line Therapy in Advanced Biliary Tract Cancer [Recruiting]

Tarceva and Capecitabine for Pancreatic Cancer [Active, not recruiting]

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer [Active, not recruiting]

A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer [Active, not recruiting]

A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer [Active, not recruiting]

A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer [Completed]

A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer [Active, not recruiting]

XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer [Active, not recruiting]

A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer [Active, not recruiting]

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer [Completed]

A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [Completed]

A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [Completed]

Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies [Completed]

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Completed]

Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer [Completed]

DOXIL® vs. Xeloda® as First Line Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older [Terminated]

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer [Recruiting]

Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer [Recruiting]

Phase I Oral mTOR Inhibitor RAD001 in Combination With Capecitabine for Metastatic Breast Cancer [Not yet recruiting]

Xeloda vs. TS-1 as First-Line Treatment in Unresectable or Recurrent Breast Cancer [Not yet recruiting]

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer [Recruiting]

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum [Withdrawn]

Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer [Completed]

IRESSAâ„¢ In Combo With Xelodaâ„¢ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure [No longer recruiting]

Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer [Recruiting]

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer [Recruiting]

Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer

Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer [Recruiting]

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer [Active, not recruiting]

Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer [Completed]

Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors [Recruiting]

Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer [No longer recruiting]

Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer [No longer recruiting]

Capecitabine in Treating Patients Who Have Undergone Previous Surgery, Radiation Therapy, and/or Chemotherapy for Head and Neck Cancer [Recruiting]

Bevacizumab and Capecitabine in Treating Frail Patients With Metastatic Colorectal Cancer [Recruiting]

Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Completed]

A Phase II Study of Oxaliplatin Capecitabine and Pre-Operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer [No longer recruiting]

Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Recruiting]

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum [Active, not recruiting]

Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors [Recruiting]

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer. [Recruiting]

Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer [Recruiting]

A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer [Recruiting]

Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer [Recruiting]

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer [Active, not recruiting]

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014